Regarding TRAF2, RIPK1, TNFRSF10D/TRAIL-R4, and NF-ΚB, differential mRNA expression profiles were identified between the cystadenoma and EOC groups, with statistically significant differences observed between primary and metastatic EOC (Figure 1). This evidence concerns the gene TRAF2 and cystadenoma.